It's rare until it happens to You
  • Who We Are
  • //
  • Research
  • //
  • Partnering
  • //
  • Products
  • //
  • FAQ
  • //
  • News
  • //
  • Awards
  • //
  • Links
  • //
  • Contact

September 13, 2011

Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation (PDF)

August 29, 2011

Mid-State Company Battles Rare Diseases (www.NewsChannel5.com)

August 5, 2011

Today Scorpions – Tomorrow Pit Vipers and Spiders (PDF)

August 3, 2011

Rare Disease Therapeutics, Inc. Obtains FDA Approval of Scorpion Sting Antivenom Anascorp® (PDF)

News

Rare Disease Therapeutics, Inc.

2550 Meridian Blvd, Suite 150
Franklin, Tennessee 37067
Phone: 615-399-0700
Fax: 615-399-1217
RDT America's First
Exclusively Orphan
Drug Company
Partnering With Us
We continually seek to form strategic alliances to acquire orphan products. By partnering with Rare Disease Therapeutics, Inc., your organization can access our experience in many therapeutic, clinical, operational, and administrative areas. // GO
Research & Development
Our product research and development focuses on the areas of oncology, genetic disorders, hematology, metabolic and respiratory diseases, envenomations, opportunistic infections, hepatic, and autoimmune diseases. // GO
Frequently Asked Questions
What are "Orphan Drugs"? Orphan products are drugs, biologics, or other therapeutics that treat diseases that affect fewer than 200,000 people in the United States. To learn more about Rare Disease Therapeutics, Inc., visit our FAQs page. // GO
© Rare Disease Therapeutics, Inc. All Rights Reserved.
Privacy Statement & Terms of Use